Hershey Upgraded to Cautious Buy on Cocoa Decline and Margin Recovery, but Volume Concerns Persist

What happened

A Seeking Alpha analyst upgraded Hershey from Sell to cautious Buy, citing declining cocoa prices, recovering margins, and rebounding earnings that improve the risk/reward profile. Revenue growth, however, remains almost entirely driven by pricing rather than volume, which raises doubts about long-term organic growth sustainability. The stock has rallied modestly over the past year and trades at about 28 times trailing earnings, but that multiple is exaggerated by 2025’s commodity-driven profit trough; a normalization of margins could bring the P/E down meaningfully. The DeepValue master report had rated HSY a WAIT due to a thin margin of safety and still-elevated input costs, but the new article argues the tide is turning. If cocoa continues to ease and pricing holds, Hershey could re-rate, but the gap between the stock price and the DCF anchor of ~$129, coupled with anemic volume growth, warrants continued caution even after the upgrade.

Implication

The near-term earnings outlook is brightening as cocoa prices retreat and management’s pricing actions begin to restore margins, which could lead to positive estimate revisions and multiple support. However, the stock remains ~45% above our DCF-derived intrinsic value, implying that a successful margin recovery is largely discounted already. Volume trends remain weak, with revenue growth almost entirely dependent on price increases, a dynamic that risks brand elasticity and market share erosion over time. The DeepValue WAIT stance is thus softened but not abandoned: the upgrade to cautious Buy is reasonable for investors with a higher tolerance for valuation risk, but we would not yet call it a compelling value opportunity. A small initial position may be warranted to track the recovery, but a full commitment should await either a pullback toward the $150s or unambiguous evidence that volumes can stabilize alongside margin improvement.

Thesis delta

The thesis shifts from a clear WAIT to a more favorable near-term outlook as declining cocoa and rebounding margins bring the earnings recovery closer. However, the stock’s premium to intrinsic value and volume challenges prevent a full-conviction Buy, making the upgrade more of a tactical shift than a structural thesis change. We now see a reasonable case for a small, cautious entry, but the margin of safety remains thin, and the core valuation risk has not been resolved.